Tumour-Informed and Tumour-Agnostic MRD Solutions for Clinical Drug Development
Time: 11:40 am
day: Day 2 - Track A (1)
Details:
- Personalised MRD detection informed by baseline tissue, blood, or urine samples
- Tumour-agnostic MRD detection independent of baseline sample availability
- Integrated into clinical trials with high-impact publications in NEJM and Nature Medicine
